Lifecore Biomedical [LFCR] vs Zoetis [ZTS] Detailed Stock Comparison

Lifecore Biomedical Inc.

NASDAQ
Loading...

Zoetis Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Lifecore Biomedical Inc. wins in 5 metrics, Zoetis Inc. wins in 15 metrics, with 0 ties. Zoetis Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lifecore Biomedical Inc. Zoetis Inc. Better
P/E Ratio (TTM) 56.23 19.58 Zoetis Inc.
Price-to-Book Ratio -17.45 15.04 Zoetis Inc.
Debt-to-Equity Ratio 414.80 279.59 Zoetis Inc.
PEG Ratio -1.24 2.81 Zoetis Inc.
EV/EBITDA 44.66 13.96 Zoetis Inc.
Profit Margin (TTM) -23.78% 28.24% Zoetis Inc.
Operating Margin (TTM) 8.18% 34.69% Zoetis Inc.
EBITDA Margin (TTM) 8.18% 34.69% Zoetis Inc.
Return on Equity 312.34% 65.99% Lifecore Biomedical Inc.
Return on Assets (TTM) -19.11% 15.26% Zoetis Inc.
Free Cash Flow (TTM) $-13.62M $2.28B Zoetis Inc.
Dividend Yield N/A 1.21% N/A
1-Year Return -25.85% -53.93% Lifecore Biomedical Inc.
Price-to-Sales Ratio (TTM) 1.51 5.26 Lifecore Biomedical Inc.
Enterprise Value $368.08M $56.75B Zoetis Inc.
EV/Revenue Ratio 2.84 6.00 Lifecore Biomedical Inc.
Gross Profit Margin (TTM) 25.04% 70.17% Zoetis Inc.
Revenue per Share (TTM) $3 $21 Zoetis Inc.
Earnings per Share (Diluted) $-1.27 $6.02 Zoetis Inc.
Beta (Stock Volatility) 0.88 0.97 Lifecore Biomedical Inc.
Short % of Float 12.08% 4.06% Zoetis Inc.

Lifecore Biomedical Inc. vs Zoetis Inc. Stock Performance Analysis

Loading Price Chart...

LFCR
ZTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lifecore Biomedical Inc.4.22%13.75%6.43%-24.48%-29.27%-29.46%
Zoetis Inc.1.51%-4.46%-31.75%-39.76%-38.95%-38.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lifecore Biomedical Inc.-25.85%-38.40%-60.63%-55.14%-16.19%-44.53%
Zoetis Inc.-53.93%-54.80%-55.66%62.09%150.53%150.53%

Performance & Financial Health Analysis: Lifecore Biomedical Inc. vs Zoetis Inc.

MetricLFCRZTS
Market Information
Market Cap i$184.39M$49.75B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i368,9722,727,710
90 Day Avg. Volume i505,5343,835,940
Last Close$5.68$167.10
52 Week Range$3.63 - $8.98$139.70 - $200.33
% from 52W High-36.75%-16.59%
All-Time High$20.75 (May 20, 1996)$249.27 (Dec 27, 2021)
% from All-Time High-72.63%-32.96%
Growth Metrics
Quarterly Revenue Growth-0.15%0.03%
Quarterly Earnings Growth0.26%0.04%
Financial Health
Profit Margin (TTM) i-0.24%0.28%
Operating Margin (TTM) i0.08%0.35%
Return on Equity (TTM) i3.12%0.66%
Debt to Equity (MRQ) i414.80279.59
Cash & Liquidity
Book Value per Share (MRQ)$-0.38$7.84
Cash per Share (MRQ)$0.47$5.48
Operating Cash Flow (TTM) i$12.57M$2.90B
Levered Free Cash Flow (TTM) i$163.59M$1.79B
Dividends
Last 12-Month Dividend Yield iN/A1.21%
Last 12-Month Dividend iN/A$2.03

Valuation & Enterprise Metrics Analysis: Lifecore Biomedical Inc. vs Zoetis Inc.

MetricLFCR (Apr 24, 2026)ZTS (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i56.2319.58
Forward P/E i-6.3015.61
PEG Ratio i-1.242.81
Price to Sales (TTM) i1.515.26
Price to Book (MRQ) i-17.4515.04
Market Capitalization
Market Capitalization i$184.39M$49.75B
Enterprise Value i$368.08M$56.75B
Enterprise Value Metrics
Enterprise to Revenue i2.846.00
Enterprise to EBITDA i44.6613.96
Risk & Other Metrics
Beta i0.880.97
Book Value per Share (MRQ) i$-0.38$7.84

Financial Statements Comparison: Lifecore Biomedical Inc. vs Zoetis Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLFCR (2025)ZTS (2025)
Revenue/Sales i128.87M9.47B
Cost of Goods Sold i88.57M2.67B
COGS % of Revenue i68.7%28.2%
Gross Profit i40.30M6.80B
Gross Margin i31.3%71.8%
Research & Development i8.26M698.00M
Operating Income (EBIT) i-12.01M3.60B
Operating Margin i-9.3%38.0%
EBITDA i-3.65M4.17B
EBITDA Margin i-2.8%44.1%
Pre-Tax Income i-38.67M3.36B
Pre-Tax Income % of Revenue i-30.0%35.5%
Income Tax i43,000687.00M
Income Tax % of Revenue i0.0%7.3%
Net Income (Profit) i-38.72M2.67B
Profit Margin i-30.0%28.2%

Balance Sheet & Liquidity Metrics

MetricLFCR (2025)ZTS (2025)
Cash & Equivalents i17.47M2.31B
Total Current Assets i82.29M6.77B
Total Current Assets % of Revenue i63.9%71.5%
Total Current Liabilities i23.57M2.24B
Total Current Liabilities % of Revenue i18.3%23.6%
Long-Term Debt i141.28M9.24B
Long-Term Debt % of Revenue i109.6%97.6%
Total Shareholders Equity i-14.20M3.33B
Retained Earnings i-223.20M13.74B
Retained Earnings % of Revenue i-173.2%145.2%
Property, Plant & Equipment i0288.00M

Cash Flow Statement Comparison

MetricLFCR (2025)ZTS (2025)
Operating Cash Flow i-1.65M2.78B
Operating Cash Flow % of Revenue i-1.3%29.3%
Capital Expenditures i-6.42MN/A
Free Cash Flow i-13.62M2.28B
FCF Margin i-10.6%24.1%
Debt Repayment i-145.76M-1.35B
Common Stock Repurchase iN/A-3.24B

Short Interest & Institutional Ownership Analysis

MetricLFCRZTS
Shares Short i2.59M15.12M
Short Ratio i5.493.60
Short % of Float i12.08%4.06%
Shares Outstanding i37.47M424.93M
Float Shares i19.84M421.29M
% Held by Insiders i1.92%0.15%
% Held by Institutions i76.45%101.50%
% Held by Public i21.63%-1.65%

Dividend Analysis & Yield Comparison: Lifecore Biomedical Inc. vs Zoetis Inc.

MetricLFCRZTS
Last 12-Month Dividend iN/A$2.03
Last 12-Month Dividend Yield iN/A1.21%
3-Year Avg Annual Dividend iN/A$1.80
3-Year Avg Dividend Yield iN/A0.29%
3-Year Total Dividends iN/A$5.39
Ex-Dividend DateN/AJan 20, 2026